Former OpenAI CTO Launches New AI Venture
February 19, 2025 - 05:07
Mira Murati, the former Chief Technology Officer of OpenAI, has embarked on an exciting new journey by co-founding Thinking Machines Lab, a fresh player in the artificial intelligence landscape. After her departure from OpenAI last year, Murati has channeled her expertise and vision into this innovative start-up, which aims to push the boundaries of AI technology.
Thinking Machines Lab is set to focus on developing cutting-edge AI solutions that address real-world challenges. With Murati at the helm, the company is expected to leverage her extensive experience in AI research and development. Known for her pivotal role in various groundbreaking projects at OpenAI, Murati's leadership is anticipated to attract significant attention within the tech community.
The launch of Thinking Machines Lab signals a growing trend of AI professionals venturing into entrepreneurship, fostering a new wave of innovation. As the demand for advanced AI applications continues to rise, Murati's new venture is poised to make a significant impact in the industry.
MORE NEWS
July 1, 2025 - 12:35
Westville Library Receives Grant for Technology and Internet EnhancementsWESTVILLE — In an era where technology is rapidly transforming our daily lives, the Westville Public Library in Vermilion County is taking significant steps to modernize its services. The library...
June 30, 2025 - 22:18
Webstar Technology Group Secures Contract for "The Forge" Project in Downtown AtlantaWebstar Technology Group, a prominent player in real estate development and digital asset innovation, has officially placed its transformative project, `The Forge,` under contract in the heart of...
June 30, 2025 - 04:30
Voice-Based Risk Assessment Firm Secures $60 Million in Series D FundingClearspeed, a prominent player in the voice-based risk assessment technology sector, has successfully raised $60 million in its Series D funding round. This latest investment elevates the company`s...
June 29, 2025 - 04:10
First Patient Enrolled in Groundbreaking Study on MicroPulse Technology for DMEA significant milestone has been reached in a clinical study evaluating the effectiveness of MicroPulse technology as an adjunct to anti-VEGF therapy for patients suffering from diabetic macular...